ÂÜÀòÂÒÂ×

Diana J. Hubbard, PhD, currently serves as a Senior Manager at Pfizer, where responsibilities include developing strategies for patient selection and integrating in vitro diagnostics (IVD) into oncology clinical trials involving antibody-drug conjugates (ADCs). Previously, Diana held a similar position at Seagen and contributed to patient selection and IVD development for drug development. At Roche, Diana advanced through roles from Scientist to Senior Scientist, focusing on regulatory submissions and assay development. Diana's academic background includes a PhD in Cancer Biology from the University of Arizona and a B.S. in Biochemistry, Molecular Biology, and Plant Genetic Engineering from New Mexico State University.